Back
Alkermes PLC Vs. Iterum Therapeutics PLC Industry Stock Comparison
Sell
47
ALKS
Alkermes PLC
Last Price:
28.60
Seasonality Move:
0.39%
Sell
42
ITRM
Iterum Therapeutics PLC
Last Price:
1.06
Seasonality Move:
6.4%
Sell
47
Alkermes PLC (ALKS)
is a Sell
Is Alkermes PLC a Buy, Sell or Hold?
- The current Alkermes PLC [ALKS] share price is $28.36. The Score for ALKS is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- ALKS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Iterum Therapeutics PLC (ITRM)
is a Sell
Is Iterum Therapeutics PLC a Buy, Sell or Hold?
- The current Iterum Therapeutics PLC [ITRM] share price is $1.09. The Score for ITRM is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- ITRM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ALKS Stock Price Chart
What is Alkermes PLC's stock price today?
-
The Alkermes PLC share price today is $28.36
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALKS is experiencing buying pressure, which is a positive indicator for future bullish movement.
ITRM Stock Price Chart
What is Iterum Therapeutics PLC's stock price today?
-
The Iterum Therapeutics PLC share price today is $1.09
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ITRM is experiencing slight selling pressure.
ALKS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.2 | Buy |
| Relative Strength Index (14 RSI): | 60.89 | Buy |
| Chaikin Money Flow: | 475837 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.09 - 28.35) | Buy |
| Bollinger Bands (100): | (23.88 - 27.26) | Buy |
ITRM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 46.65 | Sell |
| Chaikin Money Flow: | -21879 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.05 - 1.23) | Sell |
| Bollinger Bands (100): | (1.11 - 1.45) | Sell |
ALKS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.44 | Buy |
| 20-day SMA: | 27.7 | Buy |
| 50-day SMA: | 26.9 | Buy |
| 200-day SMA: | 26.53 | Buy |
| 8-day EMA: | 27.7 | Buy |
| 20-day EMA: | 27.53 | Buy |
| 50-day EMA: | 26.93 | Buy |
| 200-day EMA: | 26.48 | Buy |
ITRM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.07 | Buy |
| 20-day SMA: | 1.11 | Sell |
| 50-day SMA: | 1.2 | Sell |
| 200-day SMA: | 1.46 | Sell |
| 8-day EMA: | 1.08 | Buy |
| 20-day EMA: | 1.11 | Sell |
| 50-day EMA: | 1.17 | Sell |
| 200-day EMA: | 1.33 | Sell |
Alkermes PLC Earnings Growth & ALKS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.07 per share, an increase this year of $1.01 per share, and a decrease next year of $0.11 per share.
Iterum Therapeutics PLC Earnings Growth & ITRM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.67 per share, a decrease next quarter of $0.01 per share, an increase this year of $2.53 per share, and an increase next year of $0.21 per share.
Alkermes PLC Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Iterum Therapeutics PLC Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||